Clinical Trial Update: Circulating Tumor DNA Response In Urothelial Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial updating on circulating tumor DNA response in urothelial carcinoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Snippet

Sponsor: University of Oklahoma | Conditions: Urothelial Carcinoma | Phase 2 | Status: RECRUITING